Multicentre phase II trial of combination neoadjuvant hormone therapy and weekly docetaxel prior to radical prostatectomy in high risk localized prostate cancer (CUOG-P01a)

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 4635-4635 ◽  
Author(s):  
M. E. Gleave ◽  
K. N. Chi ◽  
L. Goldenberg ◽  
J. Chin ◽  
E. Winquist ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
High Risk ◽  
Radical Prostatectomy ◽  
Hormone Therapy ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Localized Prostate Cancer ◽  
Multicentre Phase ◽  
Weekly Docetaxel

scholarly journals Phase II Trial of Neoadjuvant Docetaxel and CG1940/CG8711 Followed by Radical Prostatectomy in Patients With High‐Risk Clinically Localized Prostate Cancer

2013 ◽  
Vol 18 (6) ◽  
pp. 687-688 ◽  
Author(s):  
Jacqueline Vuky ◽  
John M. Corman ◽  
Christopher Porter ◽  
Semra Olgac ◽  
Evan Auerbach ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
High Risk ◽  
Radical Prostatectomy ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Localized Prostate Cancer

Randomized phase II trial of neoadjuvant everolimus in patients with high-risk localized prostate cancer

2019 ◽  
Vol 37 (3) ◽  
pp. 559-566 ◽  
Author(s):  
Vadim S. Koshkin ◽  
Maria C. Mir ◽  
Pedro Barata ◽  
Anita Gul ◽  
Ruby Gupta ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
High Risk ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Localized Prostate Cancer ◽  
Randomized Phase Ii
Sign in / Sign up

Export Citation Format

Share Document